SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., April 20, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its first quarter 2016 financial results before...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., March 8, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer of...
25 Feb 2016
United Therapeutics Corporation Reports 2015 Fourth Quarter And Annual Financial Results
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 25, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the fourth quarter and year ended...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 18, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2015 financial results...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Feb. 18, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced receipt of a Paragraph IV Certification Notice Letter on February 18, 2016 from...
06 Jan 2016
United Therapeutics Corporation To Present At 34th Annual J.P. Morgan Healthcare Conference
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Jan. 6, 2016 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that Roger Jeffs, Ph.D., President and Co-Chief Executive Officer, of...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 27, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced its financial results for the third quarter ended September ...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 21, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its third quarter 2015 financial results before...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Oct. 15, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) today announced that its Board of Directors authorized the repurchase of up to an...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Sept. 30, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into a Settlement Agreement with Sandoz Inc...
19 Aug 2015
United Therapeutics Corporation Agrees to Sell Priority Review Voucher to AbbVie for $350 Million
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 19, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it has entered into an agreement to sell its Rare Pediatric Disease...
SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., Aug. 17, 2015 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that the European Commission (EC) has granted Marketing Authorisation for...